These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 990463)

  • 1. [Relationship between the development of experimental leukemia and animals' capacity for a humoral immune response].
    Levin VI; Svirnovskii AI
    Biull Eksp Biol Med; 1976 Sep; 82(9):1088-90. PubMed ID: 990463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic response of AKR mice in different phases of development of transplanted gross leukemia. II. Comparative investigation of cellular and humoral antibody formation.
    Golubska B; Szalaty H; Stelmachowska A; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):369-76. PubMed ID: 4938012
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on specific humoral immunity in leukemia.
    Bergolz VM
    Neoplasma; 1976; 23(5):457-62. PubMed ID: 790209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of fetal antigen(s) in mouse leukemia cells.
    Ortaldo JR; Ting CC; Herberman RB
    Cancer Res; 1974 Jun; 34(6):1366-71. PubMed ID: 4545252
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lack of relationship between viral leukemogenesis and immunosuppression in the mouse].
    Ruggiero RA; Dosne Pasqualini C
    Rev Argent Microbiol; 1983; 15(2):119-30. PubMed ID: 6101065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
    Kirch ME; Hammerling U
    J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.
    Herberman RB; Oren ME
    J Natl Cancer Inst; 1971 Feb; 46(2):391-6. PubMed ID: 5115906
    [No Abstract]   [Full Text] [Related]  

  • 20. Inheritance of susceptibility and resistance to Rauscher leukaemia virus.
    Tóth FD; Váczi L; Balogh M
    Acta Microbiol Acad Sci Hung; 1973; 20(3):183-9. PubMed ID: 4798829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.